Saudi Arabia Tumor Marker Market Research Report Forecast: (2022-2027)
By Type (Cancer antigen 19-9, Alpha-fetoprotein, Beta-2-microglobulin (B2M), Cancer antigen 125, Prostate-Specific Antigen, Cancer Antigen 15-3 & and CA 27-29, Thyroid Transcriptio...n factor-1, Crcinoembryonic antigen), By Application (Diagnosis, Screening, Determine response to therapy), By Cancer (Ovarian, Leukaemia, Prostate, Thyroid, Breast, Colorectal, Lung), By Region (North, West, South, East, Central) By Company (Fujirebio, Randox, Bio-Rad, Cepheid, Roche, MP Biomedicals, DiaSorin, Leica Biosystems, Biomerieux) Read more
- Healthcare
- Mar 2022
- Pages 112
- Report Format: PDF, Excel, PPT
Market Definition
A tumor marker is a substance present in the blood, urine, or tissue of the body & referred to as proteins made by the healthy & cancer cells. Tumor markers, also known as biomarkers, are any physical, cellular, chemical, or molecular change that can be noted or studied. These substances are used principally for understanding the effects of treatment, occurrence, progress, & disease risk by examining any modification in their usual amount.
Market Insights
The Saudi Arabia Tumor Marker Market is projected to grow at a substantial CAGR during the forecast period, i.e., 2022-27. The growth of the market is driven primarily by the growing focus of the Saudi government on enhancing the healthcare infrastructure, coupled with its support through massive investments, initiatives, and norms for the development of tumor markers across the country.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2017-20 |
| Base Year: 2021 | |
| Forecast Period: 2022-27 | |
| Region Covered | North, West, South, East, Central |
| Key Companies Profiled | Fujirebio, Randox, Bio-Rad, Cepheid, Roche, MP Biomedicals, DiaSorin, Leica Biosystems, Biomerieux |
| Unit Denominations | USD Million/Billion |
Besides, with an accelerating number of cancer patients and individuals seeking personalized medicines, the demand for tumor markers is surging swiftly & generating growth opportunities for the leading players to introduce treatments to the people, which, in turn, would further boost the market over the forecast years. Moreover, several pharmaceutical companies inclining toward research & developments on biomarkers to diagnose & treat cancer are also projected to augment the overall market growth through 2027.
Impact of Covid-19 on the Saudi Arabia Tumor Marker Market
The advent of Covid-19 in 2020 had a decelerating effect on most industries across Saudi Arabia, yet the Tumor Marker Market witnessed minimal impacts. Owing to the severity of the pandemic, the government had to suspend different business operations in the country and impose stringent movement restrictions & lockdowns to curb the spread of this dreadful disease.
Since the pandemic had an exponential pressure on the healthcare sector, the government & healthcare professionals prioritized addressing Covid-19 cases and put a temporary hold on other patients whose conditions were not severe and could sustain on medicines. It, in turn, introduced challenges for the leading players in tumor marker development since public gatherings & institutions were suspended. However, since the healthcare sector & medical requirements of the people were categorized as priorities, the demand for tumor markers remained prevalent amidst the crisis.
Market Segmentation
Based on the Cancer:
- Ovarian
- Leukemia
- Prostate
- Thyroid
- Breast
- Colorectal
- Lung
- Others (Liver)
Amongst them all, Breast Cancer dominated the Saudi Arabia Tumor Marker Market with the largest share in the few previous years, and the same trend is expected during 2022-27. It attributes principally to the accelerating number of breast cancer patients and the soaring demand for biomarkers (tumor markers) for diagnosis & treatments.
Besides, mounting support from the Saudi government through massive investments, various initiatives, & favorable norms, and the active participation of the leading players in the development of biomarkers for breast cancer are other aspects augmenting the overall market growth.
Moreover, increasing focus on enhancing the healthcare infrastructure & bringing technological advancements in medicine & technology to better the patient survival rates, coupled with the rising awareness among people about breast cancer through various campaigns across Saudi Arabia, shall also instigate the growth of the Tumor Marker Market in the coming years.
Based on Type:
- Cancer Antigen 19-9
- Alpha-Fetoprotein
- Beta-2-Microglobulin (B2M)
- Cancer Antigen 125
- Prostate-Specific Antigen
- Cancer Antigen 15-3 & CA 27-29
- Thyroid Transcription factor-1
- Carcinoembryonic Antigen
Here, Cancer Antigen 15-3 & CA 27-29 attained the largest market share in recent years, owing principally to the surging prevalence of breast cancer in Saudi Arabia, i.e., stimulating the demand for tumor markers to predict the patient response to chemotherapy.
Besides, increasing developments in the technology & healthcare, coupled with growing awareness about the availability & application of such solutions for treatment, diagnosis, and cure, the demand for Cancer Antigen 15-3 & CA 27-29 tumor marker is anticipated to escalate significantly and propel the overall market growth in the years to come.
Key Questions Answered in the Market Research Report:
- What are the overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares) of the Saudi Arabia Tumor Marker Market?
- What are the region-wise industry size, growth drivers, and challenges?
- What are the key innovations, opportunities, current & future trends, and regulations in the Saudi Arabia Tumor Marker Market?
- Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Saudi Arabia Tumor Marker Market based on the competitive benchmarking matrix?
- What are the key results derived from surveys conducted during the Saudi Arabia Tumor Marker Market study?
Frequently Asked Questions
- Introduction
- Product Definition
- Research Process
- Glossary
- Market Segmentation
- Executive Summary
- Saudi Arabia Healthcare Market Overview
- Impact of COVID-19 on Saudi Arabia Tumor Marker Market
- Expert Verbatim- Interview Excerpts of industry experts
- Saudi Arabia Tumor Marker Market Outlook, 2017-2027F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Type
- Cancer antigen 19-9
- Alpha-fetoprotein
- Beta-2-microglobulin (B2M)
- Cancer antigen 125
- Prostate-Specific Antigen
- Cancer Antigen 15-3 & CA 27-29
- Thyroid Transcription factor-1
- Crcinoembryonic antigen
- Others
- By Application
- Diagnosis
- Screening
- Determine response to therapy
- By Cancer
- Ovarian
- Leukaemia
- Prostate
- Thyroid
- Breast
- Colorectal
- Lung
- Others (Liver)
- By Region
- North
- West
- South
- East
- Central
- By Company
- Market Shares, By Revenue
- Strategic Factorial Indexing
- Competitor Placement in MarkNtel Quadrant
- By Type
- Ovarian Tumor Marker Market Outlook, 2017-2027F
- Market Size & Analysis
- By Revenue
- Market Share & Analysis
- By Type
- By Application
- By Region
- Market Size & Analysis
- Leukaemia Tumor Marker Market Outlook, 2017-2027F
- Market Size & Analysis
- By Revenue
- Market Share & Analysis
- By Type
- By Application
- By Region
- Market Size & Analysis
- Prostate Tumor Marker Market Outlook, 2017-2027F
- Market Size & Analysis
- By Revenue
- Market Share & Analysis
- By Type
- By Application
- By Region
- Market Size & Analysis
- Thyroid Tumor Marker Market Outlook, 2017-2027F
- Market Size & Analysis
- By Revenue
- Market Share & Analysis
- By Type
- By Application
- By Region
- Market Size & Analysis
- Breast Tumor Marker Market Outlook, 2017-2027F
- Market Size & Analysis
- By Revenue
- Market Share & Analysis
- By Type
- By Application
- By Region
- Market Size & Analysis
- Colorectal Tumor Marker Market Outlook, 2017-2027F
- Market Size & Analysis
- By Revenue
- Market Share & Analysis
- By Type
- By Application
- By Region
- Market Size & Analysis
- Lung Tumor Marker Market Outlook, 2017-2027F
- Market Size & Analysis
- By Revenue
- Market Share & Analysis
- By Type
- By Application
- By Region
- Market Size & Analysis
- Market Attractiveness Index
- By Type
- By Application
- By Cancer
- By Region
- Market Size & Analysis
- Saudi Arabia Tumor Marker Market Policies, Regulations, Product Standards
- Saudi Arabia Tumor Marker Market Trends & Insights
- Saudi Arabia Tumor Marker Market Dynamics
- Growth Drivers
- Challenges
- Impact Analysis
- Saudi Arabia Tumor Marker Market Hotspots & Opportunities
- Saudi Arabia Tumor Marker Market Key Strategic Imperatives for Success & Growth
- Saudi Arabia Tumor Marker Market Competition Outlook
- Competition Matrix
- Product Portfolio
- Research & Development
- Strategic Alliances
- Strategic Initiatives
- Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
- Fujirebio
- Randox
- Bio-Rad
- Cepheid
- Roche
- MP Biomedicals
- DiaSorin
- Leica Biosystems
- Biomerieux
- Competition Matrix
- Disclaimer
MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:
1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.
2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.
3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.
4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making
